Skip to main content

Table 1 Clinical characteristics according to different SHR tertiles

From: Association of stress hyperglycemia ratio and poor long-term prognosis in patients with myocardial infarction with non-obstructive coronary arteries

Variables

SHR1 (≤ 0.73) N = 143

SHR2 (0.73–0.84) N = 131

SHR3 (≥ 0.84)

N = 136

P value

Age (years)

64.05 ± 13.45

63.32 ± 13.45

63.22 ± 14.58

0.860

Male, n (%)

72 (50.3)

73 (55.7)

71 (52.2)

0.667

BMI (kg/m2)

24.13 ± 4.20

24.26 ± 3.15

24.28 ± 4.23

0.970

Comorbidities

 Hypertension, n (%)

70 (49.0)

69 (52.7)

76 (55.9)

0.510

 Diabetes, n (%)

28 (19.6)

23 (17.6)

28 (20.6)

0.816

 Smoking history, n (%)

57 (39.9)

51 (38.9)

64 (47.1)

0.332

 Atrial fibrillation, n (%)

20 (14.0)

8 (6.1)

21 (15.4)

0.041

 Hyperlipidaemia, n (%)

19 (13.3)

21 (16.0)

13 (9.6)

0.285

 STEMI, n (%)

45 (31.5)

44 (33.6)

39 (28.7)

0.685

Angiographic characteristics

 Normal vesselsa, n (%)

67 (46.9)

62 (47.3)

61 (44.9)

0.910

 Vessel with any stenosisb, n (%)

76 (53.1)

69 (52.7)

75 (55.1)

0.910

Echocardiography parameters

 LVEF (%)

55.68 ± 9.82

55.78 ± 10.22

52.73 ± 12.34

0.041

 LAD (mm)

37.00 ± 6.53

36.74 ± 6.46

38.71 ± 6.12

0.030

 E/e’

10.86 ± 3.20

10.43 ± 2.82

10.18 ± 2.88

0.334

 LVEDD (mm)

44.72 ± 5.10

45.30 ± 5.45

47.10 ± 5.97

0.001

 LVESD (mm)

29.73 ± 6.07

30.65 ± 12.06

32.03 ± 7.36

0.116

 TTPG (mmHg)

24.74 ± 12.74

25.24 ± 7.77

23.68 ± 6.34

0.623

Laboratory parameters

    

 HbA1c (%)

6.51 ± 1.20

6.35 ± 1.46

6.01 ± 1.23

0.005

 FBG (mmol/L)

5.13 ± 1.35

5.90 ± 1.81

7.30 ± 3.20

< 0.001

 cTnT (ng/mL)

0.42 ± 1.06

0.42 ± 1.04

1.02 ± 3.15

0.018

 Creatine kinase-MB (ng/mL)

14.89 ± 33.52

20.11 ± 53.70

24.54 ± 42.26

0.182

 NT-proBNP (pg/mL)

1477.69 ± 3573.61

4639.57 ± 405.36

6541.46 ± 560.92

0.007

 TC (mmol/L)

4.27 ± 1.09

4.15 ± 0.93

4.20 ± 1.12

0.675

 LDL-C (mmol/L)

2.50 ± 0.92

2.41 ± 0.84

2.43 ± 0.94

0.677

 HDL-C (mmol/L)

1.14 ± 0.33

1.14 ± 0.31

1.19 ± 0.37

0.445

 TG (mmol/L)

1.52 ± 1.17

1.54 ± 0.93

1.48 ± 0.98

0.873

 CRP (mg/dL)

0.68 ± 0.62

0.60 ± 0.87

0.95 ± 1.34

0.012

 WBC (109/L)

7.90 ± 2.96

7.89 ± 3.24

8.52 ± 3.74

0.208

 RBC (10 12/L)

4.34 ± 0.67

4.42 ± 0.64

4.49 ± 0.60

0.163

 Hemoglobin (g/L)

131.69 ± 23.93

133.19 ± 20.32

134.25 ± 18.08

0.599

  1. SHR stress hyperglycemia ratio, BMI body mass index, LVEF left ventricular ejection fraction, LAD left atrium diameter, E/e’ mean septal velocity, LVEDD left ventricular end-diastolic diameter, LVESD left ventricular end-systolic diameter, TTPG trans tricuspid pressure gradient, STEMI ST-segment elevation myocardial infarction, HbA1c hemoglobin A1c, FBG fasting blood glucose, cTnT cardiac troponin, NT-proBNP N-terminal pro-brain natriuretic peptide, TC total cholesterol, HDL-C high density lipoprotein, LDL-C low-density lipoprotein, TG triglyceride, CRP C reactive protein, WBC white blood cell counts, RBC red blood cell
  2. aVessels with 0% stenosis
  3. bVessels with 0–50% stenosis
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840